Physician profile
Susannah L Neff
NPI 1336208040
$6,072.35
in general payments reported to CMS, 2019-2025
19 companies · $450 in 2025
The $450 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.09 · 2020: $121 · 2021: $211 · 2022: $764 · 2023: $2,269 · 2024: $2,177 · 2025: $450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,710 · Travel and Lodging: $2,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,710.40 |
| Travel and Lodging | $2,185.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,815.69 | 2022-2025 | Infuse, Vyzulta |
| Alcon Vision LLC | $1,629.76 | 2020-2025 | Air Optix, Dailies Aqua Comfort Plus, Dailies Total1 Multifocal |
| Sun Pharmaceutical Industries INC. | $1,061.34 | 2019-2025 | Cequa |
| Johnson & Johnson Vision Care, INC. | $254.84 | 2021-2024 | Acuvue |
| Oyster Point Pharma, INC. | $235.13 | 2022-2024 | Tyrvaya |
| Biotissue Holdings INC. | $199.97 | 2022-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $184.93 | 2020-2021 | |
| Coopervision INC. | $144.36 | 2022-2023 | Myday Contact Lens |
| Lkc Technologies, INC. | $99.91 | 2024 | |
| Mallinckrodt Hospital Products INC. | $98.30 | 2024-2025 | Acthar |
| Shire North American Group INC | $59.00 | 2019 | |
| Allergan, INC. | $53.80 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $47.11 | 2024-2025 | Xdemvy |
| Abbvie INC. | $44.56 | 2022-2025 | |
| Kala Pharmaceuticals, INC. | $39.02 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $36.13 | 2025 | Iyuzeh |
| Eyevance Pharmaceuticals LLC | $32.44 | 2022 | |
| Plexus Optix, INC. | $18.22 | 2021 | |
| Harrow Eye, LLC | $17.84 | 2024 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susannah Neff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.